About GeneDx
GeneDx is a company based in Stamford (United States) founded in 2017. It operates as a HealthTech, and Professional Services. GeneDx has raised $241 million across 3 funding rounds from investors including Pfizer, Blackstone and BlackRock. GeneDx has completed 2 acquisitions, including GeneDx and LifeMap Solutions. GeneDx offers products and services including ExomeDx, GenomeDx, and GenomeDx Rapid. GeneDx operates in a competitive market with competitors including ArcherDX, Natera, Variantyx, ImaginAb and RareCyte, among others.
- Headquarter Stamford, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Genedx, Llc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of GeneDx
GeneDx offers a comprehensive portfolio of products and services, including ExomeDx, GenomeDx, and GenomeDx Rapid. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Exome sequencing is provided for higher diagnostic yield.
Comprehensive genome sequencing includes mitochondrial genome analysis.
Rapid genome sequencing aids infants in intensive care.
Unlock access to complete
Unlock access to complete
Leadership Team
20 people
Software Development Team
8 people
Finance and Accounting
7 people
Sales and Marketing
6 people
Operations Team
5 people
Board Team
5 people
Human Resources and Administration
4 people
Data Analysis and Operations Team
4 people
Unlock access to complete
Funding Insights of GeneDx
GeneDx has successfully raised a total of $241M across 3 strategic funding rounds. The most recent funding activity was a Post-IPO round of $200 million completed in May 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Post-IPO — $200.0M
-
First Round
First Round
(01 Aug 2019)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2022 | Amount | Post-IPO - GeneDx | Valuation |
investors |
|
| Jul, 2020 | Amount | Series C - GeneDx | Valuation | BlackRock | |
| Aug, 2019 | Amount | Series B - GeneDx | Valuation | Blackstone , Section 32 |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in GeneDx
GeneDx has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Pfizer, Blackstone and BlackRock. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare ecosystem is supported through investment and innovation by Deerfield.
|
Founded Year | Domain | Location | |
|
Diversified investment management is provided across multiple asset classes.
|
Founded Year | Domain | Location | |
|
Venture capital investments are made in innovative technology startups.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by GeneDx
GeneDx has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include GeneDx and LifeMap Solutions. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Mobile apps for asthma management
|
2014 | ||||
|
Genetic testing for inherited disorders is provided by the company.
|
2000 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - GeneDx
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Genedx Comparisons
Competitors of GeneDx
GeneDx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ArcherDX, Natera, Variantyx, ImaginAb and RareCyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Genomics data analysis platform for healthcare diagnostics is offered.
|
|
| domain | founded_year | HQ Location |
ImaginAb is focused on developing advanced immuno-oncology imaging technologies.
|
|
| domain | founded_year | HQ Location |
Developer of technologies for the analysis of rare and single cells in the blood
|
|
| domain | founded_year | HQ Location |
Genetic sequencing is provided for late-stage cancer patients.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Genedx
Frequently Asked Questions about GeneDx
When was GeneDx founded?
GeneDx was founded in 2017 and raised its 1st funding round 2 years after it was founded.
Where is GeneDx located?
GeneDx is headquartered in Stamford, United States. It is registered at Stamford, Connecticut, United States.
Is GeneDx a funded company?
GeneDx is a funded company, having raised a total of $241M across 3 funding rounds to date. The company's 1st funding round was a Series B of $120M, raised on Aug 01, 2019.
What does GeneDx do?
GeneDx is involved in providing advanced genomic and exome testing services to healthcare providers and patients. The company focuses on diagnosing genetic disorders through comprehensive tests like ExomeDx and GenomeDx, targeting conditions such as developmental disorders, epilepsy, autism, and cerebral palsy. Operating in the healthcare and biotechnology sector, GeneDx supports rapid diagnosis for critically ill infants and offers actionable results with clinical expertise. Their solutions are recommended as first-line tests by medical guidelines, aiming to prevent disease progression and improve patient outcomes.
Who are the top competitors of GeneDx?
GeneDx's top competitors include Natera, ImaginAb and Lantern Pharma.
What products or services does GeneDx offer?
GeneDx offers ExomeDx, GenomeDx, and GenomeDx Rapid.
How many acquisitions has GeneDx made?
GeneDx has made 2 acquisitions, including GeneDx, and LifeMap Solutions.
Who are GeneDx's investors?
GeneDx has 8 investors. Key investors include Pfizer, Blackstone, BlackRock, Deerfield, and S32.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.